Variant | Gene | Disease | Risk Allele | Score vda | Association Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
C | 0.740 | CausalMutation | CLINVAR | Activating Q209L/P mutations in GNAQ or GNA11 (GNAQ/11) are present in approximately 80% of uveal melanomas. | 22733540 | 2012 |
|||||||
|
|
G | 0.740 | CausalMutation | CLINVAR | Activating Q209L/P mutations in GNAQ or GNA11 (GNAQ/11) are present in approximately 80% of uveal melanomas. | 22733540 | 2012 |
|||||||
|
|
G | 0.740 | CausalMutation | CLINVAR | The protein kinase C inhibitor enzastaurin exhibits antitumor activity against uveal melanoma. | 22253748 | 2012 |
|||||||
|
|
A | 0.740 | CausalMutation | CLINVAR | Impact of combined mTOR and MEK inhibition in uveal melanoma is driven by tumor genotype. | 22808163 | 2012 |
|||||||
|
|
G | 0.740 | CausalMutation | CLINVAR | Impact of combined mTOR and MEK inhibition in uveal melanoma is driven by tumor genotype. | 22808163 | 2012 |
|||||||
|
|
C | 0.740 | CausalMutation | CLINVAR | The protein kinase C inhibitor enzastaurin exhibits antitumor activity against uveal melanoma. | 22253748 | 2012 |
|||||||
|
|
A | 0.740 | CausalMutation | CLINVAR | Protein kinase C inhibitor AEB071 targets ocular melanoma harboring GNAQ mutations via effects on the PKC/Erk1/2 and PKC/NF-κB pathways. | 22653968 | 2012 |
|||||||
|
|
C | 0.740 | CausalMutation | CLINVAR | Protein kinase C inhibitor AEB071 targets ocular melanoma harboring GNAQ mutations via effects on the PKC/Erk1/2 and PKC/NF-κB pathways. | 22653968 | 2012 |
|||||||
|
|
C | 0.740 | CausalMutation | CLINVAR | Impact of combined mTOR and MEK inhibition in uveal melanoma is driven by tumor genotype. | 22808163 | 2012 |
|||||||
|
|
G | 0.740 | CausalMutation | CLINVAR | Protein kinase C inhibitor AEB071 targets ocular melanoma harboring GNAQ mutations via effects on the PKC/Erk1/2 and PKC/NF-κB pathways. | 22653968 | 2012 |
|||||||
|
|
A | 0.740 | CausalMutation | CLINVAR | Activating Q209L/P mutations in GNAQ or GNA11 (GNAQ/11) are present in approximately 80% of uveal melanomas. | 22733540 | 2012 |
|||||||
|
|
A | 0.740 | CausalMutation | CLINVAR | The protein kinase C inhibitor enzastaurin exhibits antitumor activity against uveal melanoma. | 22253748 | 2012 |
|||||||
|
|
C | 0.740 | CausalMutation | CLINVAR | Mutations in GNA11 in uveal melanoma. | 21083380 | 2010 |
|||||||
|
|
G | 0.740 | CausalMutation | CLINVAR | Mutations in GNA11 in uveal melanoma. | 21083380 | 2010 |
|||||||
|
|
A | 0.740 | CausalMutation | CLINVAR | Mutations in GNA11 in uveal melanoma. | 21083380 | 2010 |
|||||||
|
|
A | 0.740 | CausalMutation | CLINVAR | Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. | 19078957 | 2009 |
|||||||
|
|
G | 0.740 | CausalMutation | CLINVAR | Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. | 19078957 | 2009 |
|||||||
|
|
C | 0.740 | CausalMutation | CLINVAR | Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. | 19078957 | 2009 |
|||||||
|
|
C | 0.740 | CausalMutation | CLINVAR | Oncogenic mutations in GNAQ occur early in uveal melanoma. | 18719078 | 2008 |
|||||||
|
|
G | 0.740 | CausalMutation | CLINVAR | Oncogenic mutations in GNAQ occur early in uveal melanoma. | 18719078 | 2008 |
|||||||
|
|
A | 0.740 | CausalMutation | CLINVAR | Oncogenic mutations in GNAQ occur early in uveal melanoma. | 18719078 | 2008 |
|||||||
|
|
A | 0.740 | CausalMutation | CLINVAR | Mutated alpha subunit of the Gq protein induces malignant transformation in NIH 3T3 cells. | 1328859 | 1992 |
|||||||
|
|
G | 0.740 | CausalMutation | CLINVAR | Mutated alpha subunit of the Gq protein induces malignant transformation in NIH 3T3 cells. | 1328859 | 1992 |
|||||||
|
|
C | 0.740 | CausalMutation | CLINVAR | Mutated alpha subunit of the Gq protein induces malignant transformation in NIH 3T3 cells. | 1328859 | 1992 |
|||||||
|
|
C | 0.740 | CausalMutation | CLINVAR | GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. | 2549426 | 1989 |